H ypertension induced by glucocorticoid hormone
is not uncommon in clinical practice. 1 Although the exact mechanisms of glucocorticoid-induced hypertension are still uncertain, enhancement of vascular responsiveness has been considered one of the major contributing factors. 2 - 3 Previously, we demonstrated that the pressor responses to angiotensin II (Ang II) and riorepinephrine are enhanced in patients with Cushing's syndrome 4 and experimental models with glucocorticoid-induced hypertension. 55 Very recently, we found that glucocorticoid potentiates inositol trisphosphate (IP3) production evoked by Ang II in cultured vascular smooth muscle cells (VSMCs), 7 and these results showed that glucocorticoid treatment would increase sensitivity to Ang II at the cellular level. In that study, the action of glucocorticoid was, in part, through prostaglandin synthesis inhibition; however, the possibility that glucocorticoid directly modulates Ang II receptor-mediated signaling pathways in VSMCs is suggested. This, together with other experimental data, makes it conceivable that glucocorticoid increases transcription and expression of a 1B -adrenergic receptors 8 and ft-adrenergic receptors in smooth muscle cells 910 and that glucocorticoid directly
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modulates the function of G proteins in several other kinds of cells.
11 '3 As to Ang II receptors, the development of nonpeptide Ang II antagonists has allowed the identification of at least two different subtypes, Ang II type 1 (AT,) receptor and Ang II type 2 (AT 2 ) receptor. 14 - 15 Recently, Murphy et al 16 succeeded in complementary DNA (cDNA) cloning of AT, receptor from rat VSMCs. These significant advances have revealed that the actions of Ang II on VSMCs are mediated primarily through the AT! receptor.
In the present study, to clarify the mechanism for glucocorticoid-enhanced Ang II receptor-mediated responses in VSMCs, the effect of glucocorticoid on AT, receptor expression and the transcription of AT, receptor gene in VSMCs were examined. Furthermore, the effect of glucocorticoid on postreceptor signaling systems in VSMCs was studied.
Methods Materials
Reagents for these studies were purchased as follows: dexamethasone; the peptidase inhibitors antipain, phosphoramidon, leupeptin, pepstatin, bestatin, amastatin, and bacitracin; and bovine serum albumin (BSA) were from Sigma Chemical Co, St Louis, Mo. The nonpeptide AT, receptor antagonist DuP 753 was a gift from Dr Smith (Du Pont de Nemours Co, Wilmington, Del). PD 123319, an AT 2 receptor antagonist, was a gift from Dr Taylor (Parke-Davis Pharmaceutical Research, Warner-Lambert Co, Ann Arbor, Mich). Ang II was from the Peptide Institute, Osaka, Japan.
125
I-Ang II and anti-G^ protein were from Du Pont NEN Research Products, Boston, Mass. Fetal calf serum (FCS) was purchased from GIBCO Laboratories, Grand Island, NY. Dulbecco's modified Eagle medium (DMEM) and phosphate-buffered
Cell Culture
VSMCs were prepared from the thoracic aorta of 6-week-old Wistar-Kyoto rats by an enzyme method previously described 7 and were cultured in DMEM containing 10% FCS, 100 U/mL penicillin, and 100 /ig/mL streptomycin. The cultures were kept at 37°C in a humid atmosphere consisting of 5% CO 2 in air, and the medium was changed every 3 or 4 days. After the cells reached confluence, the medium was changed to culture media containing various doses of dexamethasone or ethanol vehicle as a control for various periods of time before the experiments. Cells between the second and fourth passages were used for the experiments. The cells had typical smooth muscle morphology, including the presence of hills and valleys seen under a phasecontrast microscope. Cell viability was estimated by trypan blue exclusion to be approximately 90%. We used dexamethasone because of its more potent and pure glucocorticoid action than the endogenous glucocorticoid.
Radioligand Receptor Binding Assay
The specific binding of 
Isolation of Total Cellular RNA
The cells were washed three times with PBS and then lysed in 4 mol/L guanidine isothiocyanate. Total cellular RNA was isolated by the acid guanidinium/phenol/chlorofonn method. After extraction with phenol/chloroform and precipitation with ethanol, the RNA pellet was resuspended in 50 fiL of TE buffer (Tris-HCl, EDTA), pH 7.4, and quantified by absorbance measurements at 260 nm. The integrity of the purified RNA was determined by visualization of the 28S and 18S ribosomal RNA bands after electrophoresis of each RNA sample through a 1% agarose gel.
Northern Blot Hybridization
For Northern blot analysis, RNA (total cellular RNA, 20 /ig) was denatured with formamide and Formalin at 65°C for 10 minutes and fractionated by electrophoresis through a 1% agarose gel. The RNA was transferred to a nylon filter (blotting membrane Hybond-N was purchased from Amersham International, Ltd, Buckinghamshire, England). Prehybridization was conducted at 65°C for 2 hours in 5 x SSPE (1 x SSPE=0.18 mol/L sodium chloride, 10 mmol/L sodium phosphate, and 1 mmol/L EDTA, pH 7.7), 5 x Denhardt's solution, 0.5% sodium dodecyl sulfate (SDS), and heat-denatured salmon sperm DNA (1 mg/mL). A Kpn ISac I fragment that encodes the rat AT, receptor, kindly provided by Dr Inagami (Vanderbilt University, Nashville, Tenn), was used as a probe for hybridization. The filters were then hybridized at 65°C for at least 12 hours to the probe that was radiolabeled with [a-^PJdCTP by the random primer synthesis method (Random Primer DNA Labeling Kit, TaKaRa Shuzo Co, Ltd, Kyoto, Japan). After hybridization, the filter was washed twice in 2x SSC (sodium chloride and sodium citrate buffer) and 0.1% SDS at 65°C and successively in l x SSC and 0.1% SDS once and in 0.5 x SSC and 0.1% SDS once. The autoradiograms were scanned with a BAS 2000 (Fuji Film, Tokyo, Japan) and quantified. 17 '
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Measurement of Inositol 1,4,5-Trisphosphate Production
Production of IP 3 in VSMCs was measured with a radioimmunoassay kit (TRK1000, Amersham), as previously described. 7 To examine the effects of dexamethasone on postreceptor signaling systems, the accumulation of IP 3 was determined in permeabilized VSMCs by use of the nonhydrolyzable GTP analogue guanosine-5'-O-(3'-thiotriphosphate) (GTP-yS) in dexamethasone-treated (1 /imol/L for 48 hours) or nontreated cells. VSMCs were exposed to 200 U/mL a-toxin (Life Technologies, Inc, Gaithersburg, Md), a transmembrane pore-making exoprotein produced by Staphylococcus aureus, 19 for 20 minutes at 37°C in buffer containing (mmol/L) glutamate potassium salt, 150; EGTA, 5; magnesium chloride, 1; and 1,4-piperazine diethanesulfonic acid (PIPES), 10; pH 7.2, adjusted with KOH. The cells were then rinsed with the above medium and incubated with 100 fimo\fL GTP-yS for 20 minutes. IP 3 production was measured with a competitive binding assay that used a bovine-derived adrenal binding protein specific for IP 3 .
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis and Immunoblotting
The cells were washed three times with ice-cold PBS and added sample buffer (60 mmol/L Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 0.1% bromophenol blue) and boiled for 5 minutes before resolution by SDSpolyacrylamide gel electrophoresis on gels containing 12% acrylamide. The protein was loaded in 150-^tg aliquots to achieve optimal blots. Low molecular weight protein standards (Bio-Rad Laboratories, Hercules) were run in parallel with the samples under study. After electrophoresis, proteins were transferred to nitrocellulose membrane (TEF Co, Nagano, Japan), which was then blocked overnight in blocking solution (5% BSA in buffer comprising 150 mmol/L NaCl in 20 mmol/L Tris-HQ, pH 7.5). After washing, the blot was incubated for 2 hours with the first antiserum (anti-G qo ) at a 1:1000 dilution in 0.05% Tween 20 in blocking solution. After a further wash, the blot was incubated for 2 hours with the second antibody (alkaline phosphatase-conjugated goat anti-rabbit IgG, BioRad Laboratories). After the final washes, the detection was performed by the immunoblot assay procedure (Bio-Rad Laboratories). Antiserum G,,, was raised against the C-terminal sequence of G^, and recognized the 42-kD forms of G,,,.
Protein Determination
The protein levels in VSMCs were determined by the method of Pierce (Pierce Chemical Co, Rockford, III) using BSA as a standard.
Statistical Analysis
The results are expressed as mean±SEM. Statistical significance was assessed by Student's t test. Values of P<£)5 were considered to be significant. 15 ' 20 The displacement curve in dexamethasone-treated cells, expressed by percentage of control, showed that the characteristics of the Ang II receptor were similar to those in the control cells.
Results
Effects of Dexamethasone on
Next, to investigate the effect of dexamethasone on AT! receptor, VSMCs were incubated with 1 /xmol/L dexamethasone for various periods before the cells were harvested. AT, receptor number, measured with the ligand 125 I-Ang II, was unchanged during the first several hours of exposure to dexamethasone. The receptor number was found to be increased after 12 hours' exposure to dexamethasone and progressively increased to 185.6±9.8% of control at 48 hours (Fig 2). Fig 3 shows To demonstrate whether the effect of dexamethasone was through the glucocorticoid receptor, VSMCs were incubated with 10 ^mol/L RU 38486, a glucocorticoid receptor-specific antagonist, 21 with or without 1 /xmol/L dexamethasone for 48 hours. Although RU 38486 alone had no effect on the number of AT, receptors, it completely blocked the effect of 1 /xmol/L dexamethasone (Fig 5) . These results suggested that the effect of dexamethasone on AT, receptor was through the glucocorticoid-specific receptor. 
Effect of Dexamethasone on Angiotensin II Type 1 Receptor Messenger RNA Level
The steady-state AT, receptor mRNA level was measured by Northern blot analysis. Fig 6A shows Northern blot analysis of total RNA from rat VSMCs. A single band of 2.3 kb was observed in both dexamethasonetreated cells and control cells. The size of this mRNA was consistent with the previous report. 16 Fig 6B shows the ethidium bromide staining of total RNA used for Northern blot in Fig 6A . Both 28S and 18S ribosomal RNA were present in similar amounts throughout the gel. Fig 7 shows the relative increase in AT, receptor mRNA calculated by the BAS 2000 system. After 30 minutes' treatment with dexamethasone, the abundance of AT, receptor mRNA was 2.2±0.3 times control, and it was 7.8 ±0.4 times control after 24 hours' exposure to dexamethasone.
Effect of Dexamethasone on GTP Analogue-Induced IP., Production in Permeabilized Cells
To examine the effect of dexamethasone on Ang H-mediated postreceptor signaling systems in VSMCs, we first directly activated G proteins by GTPyS in permeabilized cells. GTP-yS has been shown to stimulate IP 3 accumulation and potentiate contraction of permeabilized smooth muscle. 1922 The basal intracellular IP 3 content was 4.5±0.5 pmol/10 6 cells, consistent with the previous study. 7 After treatment with 1 /xmol/L dexamethasone or ethanol vehicle for 48 hours, the cells were stimulated with GTP-yS (100 /xmol/L for 20 minutes). As shown in Fig 8, increased accumulation of IP 3 occurred in both dexamethasone-treated and control cells. However, there was no significant difference of IP 3 production between dexamethasone-treated cells and control cells. It should be noted that in the experiments conducted in the absence of a-toxin treatment, there was no rise in IP 3 levels in response to GTP-yS in both groups (data not shown).
Effect of Dexamethasone on G q Protein a-Subunit Protein Level
To examine the effect of dexamethasone on Ang II-mediated postreceptor signaling systems in VSMCs, we next examined the effect of dexamethasone on G q protein a-subunit protein level by Western blot analysis. 
Effect of Dexamethasone on Cell Numbers and Cell Protein
Dexamethasone had no significant effects on cell numbers and cell protein in VSMCs incubated for 48 hours compared with control.
Discussion
In the present study, we investigated the effects of glucocorticoid on AT, receptor, its gene expression, and postreceptor signaling systems in VSMCs. Dexamethasone induced the gene expression of AT, receptor and increased AT, receptor number through the glucocorticoid-specific receptor, without significant effect on postreceptor systems in VSMCs. These findings could potentially explain how glucocorticoid induces vascular hypersensitivity to Ang II and are quite important in elucidating the mechanism of increased vascular sensitivity that is found in patients with Cushing's syndrome. 4 The radioligand binding study using the specific receptor antagonists DuP 753 and PD 123319 disclosed that the actions of Ang II on VSMCs were mediated primarily through the AT, receptor. Moreover, treatment with dexamethasone did not alter the characteristics of Ang II receptor subtypes. From the results of the time course study, the number of AT, receptors was increased after 12 hours' exposure to dexamethasone and maintained its levels at 48 hours. This relatively long duration might account for protein synthesis, and this behavior is consistent with the general mode of action of steroid hormones. Furthermore, dexamethasone exhibited a dose-related increase in AT, receptor numbers.
The effects of glucocorticoid on the regulation of Ang II receptor have been demonstrated in in vivo and in vitro studies. Douglas 23 demonstrated that dexamethasone infusion produced downregulation of glomerular Ang II receptor obtained from sodium-loaded rats. Those results contradict our present findings. Since glomerular mesangium and vascular smooth muscle share many properties, similar actions of dexamethasone on Ang II receptor are expected. Although the exact reasons for the difference between these studies and our present findings remain to be determined, several possible explanations can be suggested. The dose of dexamethasone infused in sodium-loaded rats was lower than in our in vitro study. In our experiment, low doses of dexamethasone did not induce any significant changes in the number of AT, receptor. Second, other factors, such as low levels of circulating Ang II, may modulate the effects of glucocorticoid in sodium-loaded rats. Furthermore, it is also possible that glucocorticoid has tissue-and cell-specific regulation. Indeed, Chappell et al 24 showed that glucocorticoid downregulated both AT, and AT 2 receptors in pancreatic acinar cells.
Several recent studies have investigated the effects of glucocorticoid on the mRNA of seven transmembrane- Compared with these similarities, the reported pattern of change in /E^-adrenergic receptor gene is different. regulatory mechanisms among AT,, a 1B -, and ft-adrenergic receptor mRNA may be important, because these receptors are closely involved in cardiovascular regulation in glucocorticoid-induced hypertension. From our present study, it still remains unclear whether dexamethasone elevated transcription rate or increased the stability of ATi receptor gene product. Our data only presented the increased accumulation of AT, receptor mRNA. For most steroid-regulated genes, gene expression is effected primarily at the transcription rate. 25 Glucocorticoid has been shown, however, to have effects on mRNA stability such as insulin mRNA in insulinoma cells 26 and interleukin-1/3 mRNA in monocytic cell lines. 27 Further studies will be needed. We previously reported marked elevation of Ang IIinduced IP 3 production in response to dexamethasone exposure in VSMCs. 7 These changes (threefold) were significantly greater than could be explained by modest increases in receptor density (twofold) and led us to test the hypothesis that augmented signal transduction might be partially explained by changes in postreceptor systems. Recent advances in the investigation of G protein have demonstrated that the Ang II-linked G protein concerned in IP 3 production in VSMCs is G,. 2829 First, therefore, o-toxin-permeabilized VSMCs were used. In these cells, GTP-yS induced an increase in IP 3 production without Ang II, and 48 hours' exposure to dexamethasone did not affect the IP 3 production induced by GTP-yS. It is therefore less likely that dexamethasone exerts its action on IP 3 production through postreceptor signaling systems. However, GTP-yS might have the capability of stimulating all kinds of G proteins other than G q in VSMCs. Then, we investigated the effect of dexamethasone on G,,, protein level, and no significant changes in G qa protein level were found. The classification "G protein" is now used to refer to a family of G proteins. In G q protein, the interaction and regulation with other G proteins, such as G,, G,, and so on, were not fully understood. Therefore, it is clear that before we conclude that there is no modulatory role of dexamethasone in postreceptor signaling systems, further precise study would be needed.
In conclusion, we have first demonstrated that glucocorticoid induced the expression of the AT[ receptor gene and resulted in an increase in the number of AT! receptors through the glucocorticoid-specific receptor in VSMCs. Moreover, we also demonstrated that glucocorticoid did not exert significant action on postreceptor signaling systems. Taken together with the results of our recent study, 7 these results indicate that glucocorticoid elevates AT, receptor numbers and also enhances receptor-mediated response, that is, Ang II-stimulated IP 3 production. This evidence makes clear the mechanisms of vascular hypersensitivity to Ang II in glucocorticoid-induced hypertension.
